Adimab is the leading technology provider for therapeutic antibody drug discovery, focusing solely on our partnerships without pursuing an internal product pipeline. Since 2009, we have partnered with over 140 pharmaceutical and biotechnology companies, generating more than 650 therapeutic programs, of which more than 85 have entered clinical trials.
Role Overview:
We are seeking a focused and enthusiastic protein engineer to join our Platform Technologies group. In this role, the Research Associate will work in a small, collaborative team to execute Adimab’s platform for the discovery, optimization and characterization of protein-based therapeutics.
- Designing and executing protein engineering experiments
- Constructing yeast display libraries and performing FACS selections
- Basic protein/DNA sequence and structural analysis
- Basic yeast handling and propagation
- Collecting, organizing, and analyzing antibody characterization data
- Collaborating with colleagues and external partners
- B.S., or equivalent practical experience, with training in molecular biology, chemical engineering, or biochemistry
- At least 2 years of lab experience in an academic or industry setting
- Knowledge of molecular biology, protein engineering, structural biology, and/or flow cytometry
- Meticulous approach to benchwork and data analysis
- Experience with protein display technologies (yeast, bacterial and/or ribosomal) desired
- Knowledge of protein sequence analysis and next-generation sequencing workflows desired
- Experience with protein structural analysis or computational design methods desired
- Demonstrated ability to evaluate, interpret, and present scientific data
- Internally motivated with proven track record of operating independently at the bench and bringing projects to completion
- Excellent organization skills and the ability to manage multiple projects simultaneously
- Adaptable and productive in a fast-paced environment
- Communicates effectively and openly with colleagues and supervisors
- Resourceful with outstanding execution and problem-solving skills
- Excellent quantitative skills with a mastery of Excel
Come join us!
Our integrated antibody discovery and engineering platform provides unprecedented speed from antigen to purified, full-length human IgGs with exquisite specificity and biophysical behavior. We offer fundamental advantages by delivering diverse panels of antibodies that meet the most demanding standards for affinity, epitope specificity, species cross-reactivity, and developability. We enable our partners to rapidly expand their biologics pipelines through a broad spectrum of technology access arrangements.
As a profitable privately-held biotech company, we take a long-term view on value creation and make substantial investments in technology development, research, and our people. We offer individually tailored compensation packages comprised of a competitive salary, meaningful equity, a 2:1 401(k) match, and comprehensive health care benefits.
Located in New Hampshire’s beautiful Upper Connecticut River Valley, we are minutes from Dartmouth College, the Geisel School of Medicine, the Thayer School of Engineering, the Tuck School of Business, and the Dartmouth Hitchcock Medical Center. We are fortunate to be situated in an area that is renowned for its premier skiing, hiking, kayaking, and biking.
Top Skills
What We Do
Adimab is the most successful antibody discovery company in the industry, with 600+ discovery campaigns and 80+ clinical programs created with more than 130 partners. Our unique, yeast-based platform is a comprehensive and effective tool for the discovery and optimization of fully human monoclonal and bispecific antibodies. Our partners range from some of the biggest pharma to biotech companies at all stages to leading academic institutions. We're committed to staying at the cutting edge of protein-based therapeutic discovery to enable the highest quality IgGs, multispecifics, CARs and other modalities to allow our partners to have the most successful therapeutic programs possible.









